News
Important Only
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval For A Phase 1B/2 Clinical Trial Of Soquelitinib
June 25 (Reuters) - Corvus Pharmaceuticals Inc CRVS.O:CORVUS PHARMACEUTICALS ANNOUNCES PARTNER ANGEL PHARMACEUTICALS RECEIVED IND APPROVAL FOR A PHASE 1B/2 CLINICAL TRIAL OF SOQUELITINIB IN CHINA FOR THE TREATMENT OF ATOPIC DERMATITISReuters
Wed, Jun 25
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R)
June 25 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O:AMNEAL HIGHLIGHTS POSITIVE TOPLINE RESULTS FROM CONFIRMATORY CLINICAL STUDY OF BIOSIMILAR CANDIDATE TO XOLAIR(R) (OMALIZUMAB), DEVELOPED BY KASHIV BIOSCIENCESAMNEAL PHARMACEUTICALS INC - ADL-018 CLINICAL STUDY ACHIEVES PRIMARY AND SECONDARY ENDPO...Reuters
Wed, Jun 25
Grace Therapeutics Announces Submission Of New Drug Application To US FDA For Gtx-104
June 25 (Reuters) - Grace Therapeutics, Inc GRCE.O:GRACE THERAPEUTICS ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR GTX-104GRACE THERAPEUTICS- NDA SUBMISSION INCLUDES POSITIVE DATA FROM PHASE 3 STRIVE-ON TRIALReuters
Wed, Jun 25
Corbus Pharmaceuticals Announces First Patient Dosed With Its Nectin-4 Targeting ADC CRB-701
June 25 (Reuters) - Corbus Pharmaceuticals Holdings Inc CRBP.O:CORBUS PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED WITH ITS NECTIN-4 TARGETING ADC CRB-701 IN COMBINATION WITH PEMBROLIZUMABCORBUS PHARMACEUTICALS HOLDINGS: EXPECTS TO PROVIDE DATA UPDATE & ESTABLISH RECOMMENDED PHASE 2 DOSE IN Q4 ...Reuters
Wed, Jun 25
Ovid Therapeutics Enters Agreement With Immedica Pharma AB For Sale Of Future Ganaxolone Royalties
June 25 (Reuters) - Ovid Therapeutics Inc OVID.O:OVID THERAPEUTICS ENTERS AGREEMENT WITH IMMEDICA PHARMA AB FOR SALE OF FUTURE GANAXOLONE ROYALTIESOVID THERAPEUTICS INC - IMMEDICA TO PAY $7 MILLION FOR GANAXOLONE ROYALTY RIGHTSReuters
Wed, Jun 25
Evaxion A/S Expands Research And Development Pipeline With New Vaccine Program Targeting Group A Streptococcus
June 25 (Reuters) - Evaxion A/S EVAX.O:EVAXION A/S: EXPANDS RESEARCH AND DEVELOPMENT PIPELINE WITH NEW VACCINE PROGRAM TARGETING GROUP A STREPTOCOCCUSEVAXION A/S: NEW VACCINE PROGRAM ADDED TO PIPELINE UNDER NAME EVX-B4Reuters
Wed, Jun 25
Energy Transfer Expands LNG Supply Agreement With Chevron By 1 Mln Tonnes Per Annum From Lake Charles LNG
June 25 (Reuters) - Energy Transfer LP ET.N:ENERGY TRANSFER EXPANDS LNG SUPPLY AGREEMENT WITH CHEVRON BY 1.0 MILLION TONNES PER ANNUM FROM LAKE CHARLES LNGENERGY TRANSFER LP -UNIT SIGNS INCREMENTAL LNG SUPPLY AGREEMENT WITH CHEVRONENERGY TRANSFER LP: 20-YEAR AGREEMENT FOR 1.0 MILLION TONNES PER ANNU...Reuters
Wed, Jun 25
